Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
COSMOS PharmaceuticalCSMYF 81 3-Year Book Growth Rate is 10.30% as of Feb. 2026, which is 38% below its 10-year median of 16.50. GuruFocus rates CSMYF with a GF Score™ of 81/100 and a GF Value™ of $48.62. The stock has 2 warning signs investors should review. Among 580 Healthcare Providers & Services companies, COSMOS Pharmaceutical ranks better than 63.28% on this metric.
During the past 12 months, COSMOS Pharmaceutical's average Book Value per Share Growth Rate was 10.20% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 10.30% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 10.60% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 13.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of COSMOS Pharmaceutical was 22.60% per year. The lowest was 5.50% per year. And the median was 16.50% per year.
COSMOS Pharmaceutical (OTCPK:CSMYF) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
COSMOS Pharmaceutical 3-Year Book Growth Rate Related Terms
COSMOS Pharmaceutical 3-Year Book Growth Rate Competitor Comparison
For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
COSMOS Pharmaceutical 3-Year Book Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where COSMOS Pharmaceutical's 3-Year Book Growth Rate falls into.
COSMOS Pharmaceutical 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 10.30% mean?
COSMOS Pharmaceutical (CSMYF) has a 3-Year Book Growth Rate of 10.30% as of Feb. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for COSMOS Pharmaceutical and its competitors. This is 38% below median its historical median of 16.50. Over the past decade, COSMOS Pharmaceutical's 3-Year Book Growth Rate has ranged from 5.50 to 22.60. According to the industry distribution chart, COSMOS Pharmaceutical ranks #213 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 36.7%.
Is COSMOS Pharmaceutical's 3-Year Book Growth Rate too high?
COSMOS Pharmaceutical's current 3-Year Book Growth Rate of 10.30% is 38% below median its 10-year median of 16.50. Over the past 10 years, this metric has ranged from a low of 5.50 to a high of 22.60. The Healthcare Providers & Services industry median 3-Year Book Growth Rate is 5.45. COSMOS Pharmaceutical's value of 10.30% is 89% above this industry median. Based on the distribution chart, COSMOS Pharmaceutical ranks #213 out of 580 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, COSMOS Pharmaceutical has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does COSMOS Pharmaceutical's 3-Year Book Growth Rate compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, COSMOS Pharmaceutical ranks #213 out of 580 companies for 3-Year Book Growth Rate. This puts COSMOS Pharmaceutical in the upper half of its industry. The industry median 3-Year Book Growth Rate is 5.45. COSMOS Pharmaceutical's value of 10.30% is 89% above this benchmark. Historically, COSMOS Pharmaceutical's own 3-Year Book Growth Rate has ranged from 5.50 to 22.60 over the past decade. While the company's 10-year median is 16.50 vs. the industry median of 5.45, COSMOS Pharmaceutical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Book Growth Rate among Healthcare Providers & Services companies is 5.45, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. COSMOS Pharmaceutical's current 3-Year Book Growth Rate of 10.30% is 89% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for COSMOS Pharmaceutical and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Book Growth Rate is 5.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. COSMOS Pharmaceutical's current 3-Year Book Growth Rate is 10.30%, which is 38% below median its own 10-year median of 16.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is COSMOS Pharmaceutical stock overvalued right now?
COSMOS Pharmaceutical (CSMYF) has a current 3-Year Book Growth Rate of 10.30%. The stock's GF Value™ is $48.62, compared to a current price of $37.06 — trading 23.8% below its estimated fair value. The current 3-Year Book Growth Rate is 10.30%, which is 38% below median its 10-year median of 16.50 and 89% above the Healthcare Providers & Services industry median of 5.45. COSMOS Pharmaceutical's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For COSMOS Pharmaceutical (CSMYF), the current 3-Year Book Growth Rate is 10.30% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is COSMOS Pharmaceutical (CSMYF) Overvalued in 2026?
Based on GuruFocus' analysis, COSMOS Pharmaceutical stock appears to be undervalued.
The current stock price of $37.06 is trading 23.8% below its estimated GF Value™ of $48.62.
Key valuation signals for CSMYF:
3-Year Book Growth Rate: 10.30% (38% below median its 10-year median of 16.50)
GF Value™: $48.62 vs. price of $37.06 (23.8% below fair value)
Industry Position: 89% above the Healthcare Providers & Services median (#213 of 580)
No single metric tells the full story. See the CSMYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company emphasizes convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. It also operates a private grocery brand called ON 365.
81GF Score
Get the complete analysis for CSMYF
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSMYF has been successfully added to your 
